Physician profile
Emily K Rekuc
NPI 1942491634
$7,707.04
in general payments reported to CMS, 2019-2025
32 companies · $667 in 2025
The $667 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,286 · 2020: $436 · 2021: $572 · 2022: $3,625 · 2023: $598 · 2024: $523 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,787.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,687.83 | 2019-2022 | |
| Abbvie INC. | $688.07 | 2019-2024 | |
| Therapeuticsmd, INC. | $482.54 | 2019-2022 | |
| Daiichi Sankyo INC. | $447.52 | 2020-2025 | Injectafer |
| Biogen, INC. | $307.68 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $273.14 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device, Aptima |
| Mayne Pharma Commercial LLC | $259.35 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $164.41 | 2023-2025 | Myfembree |
| Pfizer INC. | $157.19 | 2021-2025 | |
| Organon LLC | $145.48 | 2021-2022 | |
| Aspira Women'S Health INC | $119.14 | 2022-2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $92.08 | 2019-2025 | |
| Coopersurgical, INC. | $90.19 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Davol INC. | $78.37 | 2022 | |
| Astellas Pharma US INC | $78.23 | 2023-2024 | Veozah |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $73.18 | 2024 | Proclaim |
| Amag Pharmaceuticals, INC. | $68.15 | 2019-2020 | |
| Ethicon US, LLC | $66.75 | 2020-2025 | Stratafix, Dermabond Prineo, Monocryl |
| Merck Sharp & Dohme LLC | $63.88 | 2019-2021 | |
| Becton, Dickinson and Company | $44.95 | 2019 | |
| Agile Therapeutics, INC. | $44.74 | 2022 | |
| Evofem Biosciences, INC. | $43.16 | 2020-2021 | |
| Shield Therapeutics INC | $33.36 | 2025 | |
| Novo Nordisk INC | $32.89 | 2022-2023 | Wegovy |
| Baxter Healthcare | $30.90 | 2025 | Perclot |
| Smith+Nephew, INC. | $26.92 | 2025 | Pico 14 |
| Allergan, INC. | $22.40 | 2020 | |
| Lupin INC. | $20.99 | 2019 | |
| Exeltis, USA INC. | $17.27 | 2022 | |
| Integra Lifesciences Corporation | $16.65 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Dexcom, INC. | $15.15 | 2023 | Dexcom G6 Transmitter |
| Avion Pharmaceuticals | $14.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Rekuc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.